The pharmaceutical industry seems besieged on all sides, with declining R&D productivity, expiring patents on blockbuster products and relentless downward pricing pressure forcing companies to look closely at the bottom line. One affect of this onslaught has been an upsurge in the level of M&A activity as players within the industry consolidate to cut costs, expand research pipelines and lengthen geographic reach.
11-Feb-2013 - Sun Pharmaceutical Industries has abandoned its long running efforts to buy Israel’s Taro, explaining the move is in the best interest of shareholders.
21-Jan-2013 - BASF has had its offer for omega-3 API maker Pronova Biopharma accepted by 97.7 per cent of the Norwiegan firm’s shareholders.
18-Jan-2013 - German chemicals giant BASF expects its revised takeover bid for Norwegian omega-3 API manufacturer Pronova Biopharma ASA to be accepted by resistant shareholders.
15-Jan-2013 - BASF says revised offer for omega-3 API maker Pronova Biopharma is fair value given recent Greek Government decision to stop reimbursing two key drugs.
20-Dec-2012 - German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most...
26-Nov-2012 - BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.
08-Oct-2012 - in-Pharmatechnologist.com is going to Madrid, Spain to meet API and excipient makers, Biopharma firms, processing tech developers and contract services organisation gathered for one of the drug industry's biggest trade shows....
07-Aug-2012 - BD is on the lookout for more acquisitions with firms it can easily “plug in” to its business.
23-Jul-2012 - WAPMA and PMGMAN are calling on African Governments to pump more money into R&D in order to boost the continent’s pharmaceutical manufacturing sector.
09-Jul-2012 - Pharma execs are now spending as much time dealing with increasing levels of regulations as they spend on growing their businesses, according to KPMG.
28-Jun-2012 - Bosch Packaging says it is now developing a big batch version of its new X-ray capsule inspection tech.
27-Jun-2012 - PPMA is fearful that the Government of Pakistan’s recent call for more foreign investment in the local pharma sector will go unheard because the industry is already overcrowded.
06-Jun-2012 - AMPAC is selling its aerospace business after deciding it lacked the “horsepower” to grow both it and the pharmaceutical unit.
04-Jun-2012 - The new Generic Drugs User Fee Act (GDUFA) means a “level playing field” for drugmakers, according to SOCMA members.
04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.
31-May-2012 - Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.
29-May-2012 - Biopharma mergers are a “key problem” for manufacturing quality teams as the loss of focus can lead to regulatory actions, a compliance expert said.
12-Apr-2012 - in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans...
08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.
27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.
23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
12-Jan-2012 - NantWorks has unveiled plans to pump $85.5m into a new oncology and critical care injectables manufacturing plant in Terre Haute, Indiana.
10-Jan-2012 - Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.
09-Jan-2012 - Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.